Cantor Fitzgerald Reiterates Overweight on Core Scientific, Maintains $39 Price Target

Cantor Fitzgerald analyst Brett Knoblauch has reiterated an Overweight rating on Core Scientific (NASDAQ: CORZ) while maintaining a price target of $39 for the stock. This indicates a positive outlook for the company's performance in the market.